5-132387134-A-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003060.4(SLC22A5):āc.934A>Gā(p.Ile312Val) variant causes a missense change. The variant allele was found at a frequency of 0.00148 in 1,614,112 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003060.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00107 AC: 163AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000851 AC: 214AN: 251494Hom.: 0 AF XY: 0.000839 AC XY: 114AN XY: 135922
GnomAD4 exome AF: 0.00152 AC: 2228AN: 1461864Hom.: 3 Cov.: 32 AF XY: 0.00152 AC XY: 1106AN XY: 727226
GnomAD4 genome AF: 0.00106 AC: 162AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000927 AC XY: 69AN XY: 74444
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
- -
This variant is associated with the following publications: (PMID: 20574985, 18337137, 28841266) -
- -
- -
Renal carnitine transport defect Uncertain:1Benign:3
- -
- -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
- -
not specified Uncertain:1
Variant summary: SLC22A5 c.934A>G (p.Ile312Val) results in a conservative amino acid change located in the major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00085 in 251494 control chromosomes, predominantly at a frequency of 0.0017 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SLC22A5 causing Systemic Primary Carnitine Deficiency (0.00085 vs 0.0046), allowing no conclusion about variant significance. c.934A>G has been reported in the literature as a VUS in the heterozygous state in individuals with cardiomyopathy suspected of Systemic Primary Carnitine Deficiency and as an uninformative genotype (i.e. zygosity not specified) in a case of sudden unexplained death (e.g. Amat di San Filippo_2008, Li_2010, Christiansen_2016). These reports do not provide unequivocal conclusions about association of the variant with Systemic Primary Carnitine Deficiency. Publications reporting experimental evidence evaluating an impact on protein function found that the variant has little impact on carnitine transport, maintaining above 65% of WT activity (e.g. Amat di San Filippo_2008, Frigeni_2017). The following publications have been ascertained in the context of this evaluation (PMID: 18337137, 27650965, 28841266, 20574985). Six submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as either likely benign (n=4) or VUS (n=2). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at